percutalgine

used to treat benign joint conditions; consists of dexamethasone acetate, salicylamide, and hydroxyethyl salicyate

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Tendinopathy (Tendonitis) 05/01/2012 - "Percutalgine(®) (dexamethasone acetate, salicylamide and hydroxyethyl salicylate) is a topical drug marketed for treatment of benign joint conditions such as mild tendinitis, small joint arthritis and sprains. "
2.	Sprains and Strains (Sprain) 05/01/2012 - "Percutalgine(®) (dexamethasone acetate, salicylamide and hydroxyethyl salicylate) is a topical drug marketed for treatment of benign joint conditions such as mild tendinitis, small joint arthritis and sprains. "
3.	Contact Dermatitis (Eczema, Contact) 05/01/2012 - "The main cutaneous side effect of Percutalgine(®) (n=41) was contact dermatitis with secondary extension in 15 cases. "
4.	Arthritis (Polyarthritis) 05/01/2012 - "Percutalgine(®) (dexamethasone acetate, salicylamide and hydroxyethyl salicylate) is a topical drug marketed for treatment of benign joint conditions such as mild tendinitis, small joint arthritis and sprains. "
5.	Anaphylaxis (Anaphylactic Shock) 02/01/2003 - "Anaphylactic shock with percutalgine."